All available EMRs were searched to document the details of any type or combination of airway directed inhaled pharmacotherapy prescribed, more specifically—SABA (salbutamol); SAMA (ipratropium); LABA (formaterol, indacaterol, olodaterol, salmeterol, vilanterol); LAMA (aclidinium, glycopyronium, tiotropium, umeclidinium) and ICS (beclomethasone, budesonide, fluticasone). If the patients were identified to have been prescribed multiple/change in similar class of inhaled pharmacotherapy during the study period, the most recent/last prescribed type of therapy was included in the analysis. Patients inhaled pharmacotherapy use was defined as:
Protocol detail
Comprehensive Airway Pharmacotherapy Assessment
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Beclomethasone
Budesonide
Fluticasone
Indacaterol
Ipratropium
Olodaterol
Patients
Pharmacotherapy
Salbutamol
Salmeterol
Therapy
Tiotropium
Umeclidinium
Vilanterol
Corresponding Organization : Flinders University
Other organizations : Charles Darwin University, University of Eastern Finland, Menzies School of Health Research, Northern Territory Health Services
Top 5 similar protocols
Variable analysis
independent variables
- SABA (salbutamol)
- SAMA (ipratropium)
- LABA (formaterol, indacaterol, olodaterol, salmeterol, vilanterol)
- LAMA (aclidinium, glycopyronium, tiotropium, umeclidinium)
- ICS (beclomethasone, budesonide, fluticasone)
- Patients' inhaled pharmacotherapy use
- If the patients were identified to have been prescribed multiple/change in similar class of inhaled pharmacotherapy during the study period, the most recent/last prescribed type of therapy was included in the analysis.
- The input protocol does not explicitly mention any independent variables that were manipulated by the researchers. The independent variables listed are the different types or combinations of airway directed inhaled pharmacotherapy that were documented.
- The dependent variable is the patients' inhaled pharmacotherapy use, which was the measured outcome.
- The control variable is that the most recent/last prescribed type of therapy was included in the analysis if the patients were prescribed multiple/changes in similar class of inhaled pharmacotherapy during the study period.
Annotations
Based on most similar protocols
Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.
Sign up for free or login to display all annotations
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!